Cross Border
-
Fashion's hottest company... is based in Maine
While Lands' End and other rivals struggle, 102-year-old LL Bean is thriving, thanks to a trendy boot—and an old-school workforce that doesn't cut corners
-
Revenge of the record labels
While Jay Z's streaming service grabs headlines, music's majors are quietly hijacking the multibillion-dollar digital revolution
-
The all seeing eye: Protecting networks from hackers
A father-son duo came from out of nowhere with a more clever idea to protect networks from hackers—and now have a $1.75 billion startup with $160 million in the bank
-
Tesla meets Vespa
A startup is selling Asia's urban millions on a smartphone-sleek electric scooter to replace an ocean of dirty motorbikes
-
Cyanogen giving Apple, Google a run for their money
A brazen startup has a very real shot at busting up the world's smartphone duopoly
-
Imgur: A viral content empire
Alan Schaaf transformed a simple file uploader into a viral content empire. Now he has to turn Imgur into a business
-
Benchmark's power of five
Uber is also the latest hit for Benchmark, a firm whose record makes other VC shops look overhyped and overstaffed
-
Chris Sacca, the venture cowboy
Chris Sacca came from nowhere to assemble the greatest angel portfolio-Twitter, Uber, Instagram-in Silicon Valley history. And he's ticked off a lot of people along the way
-
Datto and the million-dollar data backup business
Austin McChord makes big money by selling peace of mind to small businesses hoping to avoid the catastrophe of data loss
-
Yumanity and the upcoming boom in brain medicines
Advances in genetics and clinical science could lead to a flood of new treatments for depression, Alzheimer's, and even schizophrenia. That's giving hope to millions of patients-and rebooting one of the biggest markets in the history of the drug business
-
Actavis and the art of billion-dollar drug dealing
Brent Saunders generated $25 billion in value for investors by flipping drug companies rather than discovering new drugs. Is this the future of the pharmaceutical business?